Rose Schneider Krivich

RENAL DIALYSIS

777 NORTH ST

Rose is the content specialist for Medical Economics.

Articles

Anti-seizure drug gets boxed warning for eye damage risks

November 13, 2013

The FDA has approved changes to the drug label of the anti-seizure drug ezogabine (Potiga), underscoring risks of abnormalities to the retina in the eye, potential vision loss, and skin discoloration-all of which may become permanent.